RxDoctor Payments Data

Michelle Jones

Family · Burlingame, CANPI 1609598028

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $135,219 of the $147,180 with a category attached, or 91.9%. Galderma Laboratories, L.p. accounts for 85.5% of it on its own, with 3 other manufacturers making up the rest. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$147,180in general payments, 2019–2025

Across 259 payments — averaging $568.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Galderma Laboratories, L.p.$126K
  • AbbVie$21K
  • Revance Therapeutics, Inc.$197
  • Merz North America, Inc.$159

What the payments were for

  • Consulting fees$6700%
  • Speaking & faculty fees$135,21992%
  • Travel & lodging$7,0775%
  • Food & beverage$4,1983%
  • Education$170%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Galderma Laboratories, L.p.142$125,839
AbbVie(2 entities)104$20,984
Revance Therapeutics, Inc.7$197
Merz North America, Inc.6$159

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$147,180 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.

See all family providers in California

Other family in Burlingame

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →